SMAD3 and diabetes mellitus: Moreover, the reduction in the number of WT1-positive podocytes is alleviated in Smad3+/-;db/db mice compared with db/db mice, suggesting that Smad3 activation is involved in podocyte damage in diabetes mellitus.